You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

B-Cell Malignancies

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NSCLC Trial in Kansas City (Non-ablative SBRT)

Recruiting
  • Non-small Cell Lung Cancer
  • Non-ablative SBRT
  • Kansas City, Kansas
    University of Kansas Medical Center
Mar 21, 2022

Chronic Lymphocytic Leukemia Trial in Worldwide (Acalabrutinib (ACP-196), Rituximab, Idelalisib)

Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • Acalabrutinib (ACP-196)
  • +3 more
  • Chandler, Arizona
  • +156 more
Jun 2, 2022

Squamous Cell Carcinoma Trial in France (Onivyde, Paclitaxel)

Recruiting
  • Squamous Cell Carcinoma
  • Amiens, France
  • +8 more
Dec 6, 2021

Schizophrenia Trial in Shanghai (Cognitive Remediation Therapy, Clozapine)

Completed
  • Schizophrenia
  • Shanghai, Shanghai, China
    Huangpu District Mental Health Center
Dec 19, 2021

Basal Cell Carcinoma, Elderly Trial in Ghent (Standard of care, Monitoring)

Recruiting
  • Basal Cell Carcinoma
  • Elderly
  • Standard of care
  • Monitoring
  • Ghent, East Flanders, Belgium
    Department of Dermatology, Ghent University Hospital
Dec 5, 2022

Oral Mucositis, Lymphoma, Multiple Myeloma Trial in Seoul (MIT-001, normal saline)

Recruiting
  • Oral Mucositis
  • +3 more
  • Seoul, Korea, Republic of
  • +1 more
Aug 9, 2022

NSCLC Trial in China (JAB 21822)

Recruiting
  • Non-small Cell Lung Cancer
  • JAB 21822
  • Beijing, Beijing, China
  • +20 more
Sep 26, 2022

Hepatic Impairment Trial in Miami, Orlando, Knoxville (Enasidenib)

Recruiting
  • Hepatic Impairment
  • Miami, Florida
  • +4 more
Nov 27, 2022

Healthy, Sickle Cell Anemia Trial in United States (Placebo, PF-07209326)

Recruiting
  • Healthy
  • Sickle Cell Anemia
  • Placebo
  • PF-07209326
  • New Haven, Connecticut
  • +11 more
Oct 10, 2022

Relapsing Multiple Sclerosis Trial in Boston (Ofatumumab, [F-18]PBR06)

Recruiting
  • Relapsing Multiple Sclerosis
  • Boston, Massachusetts
    Partners MS Center, 60 Fenwood Road
Jul 20, 2021

Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia Recurrent Trial in Beijing (CD123-CAR-NK cells)

Recruiting
  • Acute Myeloid Leukemia Refractory
  • Acute Myeloid Leukemia Recurrent
  • CD123-CAR-NK cells
  • Beijing, Beijing, China
    The Fifth Medical Center of Chinese People's Liberation Army (PL
Oct 24, 2022

Castration-Resistant Prostate Carcinoma, Prostate Adenocarcinoma Trial in Seattle (Olaparib)

Recruiting
  • Castration-Resistant Prostate Carcinoma
  • Prostate Adenocarcinoma
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Aug 23, 2022

Cutaneous Squamous Cell Carcinoma Trial in Italy (Cemiplimab)

Recruiting
  • Cutaneous Squamous Cell Carcinoma
  • Bagno A Ripoli, Firenze, Italy
  • +6 more
Jul 27, 2022

Hepatocellular Carcinoma, Liver Cancer, Adult, Liver Tumor Trial in Duarte (ECT204 T cells)

Recruiting
  • Hepatocellular Carcinoma
  • +3 more
  • ECT204 T cells
  • Duarte, California
  • +1 more
Jan 9, 2023

Immunotherapy + Chemotherapy in Non-Small Cell Lung Cancer

Recruiting
  • Non-small Cell Lung Cancer
    • Lille, France
    • +3 more
    Jan 25, 2023

    Non-Clear Cell Renal Cell Carcinoma Trial in Duarte (XL092, Nivolumab, Sunitinib Malate)

    Recruiting
    • Non-Clear Cell Renal Cell Carcinoma
    • Duarte, California
      Exelixis Clinical Site #1
    Jan 13, 2023

    Cancer Distress, Cancer Coping, Hematopoetic Stem Cell Transplant Trial in Stanford (Aromatherapy Inhaler)

    Not yet recruiting
    • Cancer Distress
    • +3 more
    • Aromatherapy Inhaler
    • Stanford, California
      Aubrey Florom-smith
    Aug 8, 2022

    Non Small Cell Lung Cancer Trial in Shanghai (CS1001 mAb, CS1001 )

    Active, not recruiting
    • Non Small Cell Lung Cancer
    • CS1001 monoclonal antibody
    • CS1001 placebo
    • Shanghai, Shanghai, China
      Shanghai Pulmonary Hospital
    Nov 8, 2022

    Malignant Solid Tumor Trial in United States (drug, other, procedure)

    Active, not recruiting
    • Malignant Solid Neoplasm
    • Baltimore, Maryland
    • +5 more
    Nov 8, 2022

    Septic Shock, Stroke Hemorrhagic, Strokes Thrombotic Trial (Oral Bedtime Melatonin, Placebo suspension or capsule)

    Not yet recruiting
    • Septic Shock
    • +3 more
    • Oral Bedtime Melatonin
    • Placebo suspension or capsule
    • (no location specified)
    Nov 26, 2023

    ADHD Symptoms Trial in Philadelphia (Positive Behavior Management Toolkit)

    Not yet recruiting
    • Attention Deficit Hyperactivity Disorder Symptoms
    • Positive Behavior Management Toolkit
    • Philadelphia, Pennsylvania
      Children's Hospital of Philadelphia
    Aug 3, 2022

    NSCLC Trial in United States (Canakinumab, Durvalumab, Radiation therapy)

    Recruiting
    • Non-small Cell Lung Cancer
    • Basking Ridge, New Jersey
    • +6 more
    Aug 15, 2022

    GCF miRNA-223 , -214 Levels in Smokers and Nonsmokers

    Completed
    • Periodontitis, Adult
    • miRNA-223 & -214 detection
    • Fayoum, Egypt
      faculty of dentistry, Fayoum university
    Sep 26, 2023

    LSCI and Thermography in Diabetic Foot Patients Affected by

    Not yet recruiting
    • Diabetes Mellitus, Type 2
    • +2 more
      • (no location specified)
      Mar 30, 2023

      Papillary Renal Cell Carcinoma Trial (Pembrolizumab, Placebo)

      Not yet recruiting
      • Papillary Renal Cell Carcinoma
      • (no location specified)
      Nov 24, 2023